Exact Mass: 306.0044066
Exact Mass Matches: 306.0044066
Found 230 metabolites which its exact mass value is equals to given mass value 306.0044066,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Uridine 2',3'-cyclic phosphate
C9H11N2O8P (306.02530160000003)
Uridine 2,3-cyclic phosphate is a cyclic nucleotide. A cyclic nucleotide is any nucleotide in which the phosphate group is bonded to two of the sugars hydroxyl groups, forming a cyclical or ring structure. Cyclic phosphates are commonly found at the 3 end of mRNAs and other small RNAs. Uridine 2,3-cyclic phosphate is a substrate for the enzyme 2,3-cyclic nucleotide-3-phosphodiesterase (CNPase, EC 3.1.4.37) which hydrolyses it to Uridine 2-phosphate. CNPase is a unique RNase in that it only cleaves nucleoside 2,3-cyclic phosphates and not the RNA internucleotide linkage, like other RNases such as RNase A and RNase T1. [HMDB] Uridine 2,3-cyclic phosphate is a cyclic nucleotide. A cyclic nucleotide is any nucleotide in which the phosphate group is bonded to two of the sugars hydroxyl groups, forming a cyclical or ring structure. Cyclic phosphates are commonly found at the 3 end of mRNAs and other small RNAs. Uridine 2,3-cyclic phosphate is a substrate for the enzyme 2,3-cyclic nucleotide-3-phosphodiesterase (CNPase, EC 3.1.4.37) which hydrolyses it to Uridine 2-phosphate. CNPase is a unique RNase in that it only cleaves nucleoside 2,3-cyclic phosphates and not the RNA internucleotide linkage, like other RNases such as RNase A and RNase T1.
2-(3,4-Dihydroxybenzoyloxy)-4,6-dihydroxybenzoate
2-(3,4-dihydroxybenzoyloxy)-4,6-dihydroxybenzoate is part of the Flavonoid metabolism pathway. It is a substrate for: Pirin.
Kinobscurinone
An organic heterotetracyclic compound that is 10,11-dihydro-5H-benzo[b]fluorene substituted by a methyl group at position 1, hydroxy groups at positions 4 and 9, and oxo groups at positions 5, 10 and 11.
Vadadustat
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials B - Blood and blood forming organs > B03 - Antianemic preparations C78275 - Agent Affecting Blood or Body Fluid C471 - Enzyme Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Vadadustat (PG-1016548) is a titratable, oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor[1]. Vadadustat is an erythropoiesis-stimulating agent and has the potential for anemia treatment in chronic kidney disease in vivo[1][2].
4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphate
4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphate belongs to the family of Hydroxy Fatty Acids. These are fatty acids in which the chain bears an hydroxyl group.
4-hydroxy-5-[4-hydroxy-3-(sulfooxy)phenyl]pentanoic acid
4-hydroxy-5-[4-hydroxy-3-(sulfooxy)phenyl]pentanoic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 5-(3,4-dihydroxyphenyl)-4-hydroxypentanoic acid. It is generated by Sulfotransferase 1A3 (P0DMM9) and Sulfotransferase enzymes via a -3-O-sulfation-of-phenolic-compound reaction. This -3-O-sulfation-of-phenolic-compound occurs in humans.
4-Hydroxy-5-(3',4'-dihydroxyphenyl)-valeric acid 4'-sulfate
4-Hydroxy-5-(3',5'-dihydroxyphenyl)-valeric acid sulfate
2,2-Dichloro-N-[2-hydroxy-1-(hydroxymethyl)-2-(4-nitrosophenyl)ethyl]acetamide
C11H12Cl2N2O4 (306.01740920000003)
2-[(4-Phenoxyphenyl)sulfonylmethyl]thiirane
C15H14O3S2 (306.03843340000003)
(-)-Mintlactone
(-)-mintlactone is a member of the class of compounds known as benzenesulfonyl compounds. Benzenesulfonyl compounds are aromatic compounds containing a benzenesulfonyl group, which consists of a monocyclic benzene moiety that carries a sulfonyl group (-)-mintlactone is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). (-)-mintlactone can be found in peppermint, which makes (-)-mintlactone a potential biomarker for the consumption of this food product.
uracil 5-beta-D-ribofuranosyl-2,3-cyclic monophosphate
C9H11N2O8P (306.02530160000003)
3,5-Dihydroxy-1H,3H-2-benzopyrano[6,5,4-mna]xanthene-1-one
3,4-dihydroxy-5-phenyl-naphthalene-1,8-dicarboxylic acid anhydride|3,4-Dihydroxy-5-phenylnaphthalsaeureanhydrid|5,6-Dihydroxy-7-phenyl-1H,3H-naphtho[1,8-cd]pyran-1,3-dione|5,6-dihydroxy-7-phenyl-3H-benzo[de]isochromene-1,3-dione
Methyl brevifolincarboxylate
Methyl brevifolincarboxylate is an organic heterotricyclic compound that is 1,2,3,5-tetrahydrocyclopenta[c]isochromene substituted by hydroxy groups at positions 7, 8 and 9, oxo groups at positions 3 and 5 and a methoxycarbonyl group at position 1. Isolated from Phyllanthus urinaria and Phyllanthus niruri, it exhibits vasorelaxant activity. It has a role as a metabolite, a vasodilator agent, an EC 5.99.1.2 (DNA topoisomerase) inhibitor, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, a radical scavenger and a platelet aggregation inhibitor. It is an organic heterotricyclic compound, a delta-lactone, a member of phenols and a cyclic ketone. Methyl brevifolincarboxylate is a natural product found in Euphorbia maculata and Phyllanthus niruri with data available. An organic heterotricyclic compound that is 1,2,3,5-tetrahydrocyclopenta[c]isochromene substituted by hydroxy groups at positions 7, 8 and 9, oxo groups at positions 3 and 5 and a methoxycarbonyl group at position 1. Isolated from Phyllanthus urinaria and Phyllanthus niruri, it exhibits vasorelaxant activity.
4-Chloro-3,7-dihydroxy-9-methoxy-1-methyl-6H-dibenzo[b,d]pyran-6-one
4-Chloro-1,6-dihydroxy-3-methoxy-8-methyl-9H-xanthen-9-one
9H-Xanthen-9-one, 2-chloro-1,8-dihydroxy-5-methoxy-6-methyl-
2-Chloro-3,7-dihydroxy-9-methoxy-1-methyl-6H-dibenzo[b,d]pyran-6-one
ascidiathiazone B
C12H6N2O6S (305.99465760000004)
An organic heterotricyclic compound, that is 5,10-dioxo-5,10-dihydro-1H-[1,4]thiazino[3,2-g]quinoline 4,4-dioxide substituted at position 7 by a carboxy group. It is an anti-inflmmatory alkaloid obtained from Aplidium.
6-Deoxy,6beta-chloro-Cyathiformine B|cyathiformine C|cyathioformine C
C12H15ClO7 (306.05062699999996)
3,5-cUMP|3,5-cyclic UMP|CUMP|cyclic uridine 3,5-monophosphate|Cyclic-3,5-UMP|O3,O5-hydroxyphosphoryl-uridine|uridine 3,5-cyclic monophosphate
C9H11N2O8P (306.02530160000003)
5-((E)-2-Oxo-benzofuran-3-yliden)-3-phenyl-furan-2,4-dion|5-((E)-2-oxo-benzofuran-3-ylidene)-3-phenyl-furan-2,4-dione
luteolinidin
Luteolinidin chloride is an anthocyanidin chloride that has luteolinidin as the cationic counterpart. It contains a luteolinidin. Luteolinidin is a natural deoxyanthocyanidin, isolated from Sorghum bicolor [1]. Luteolinidin is a potent CD38 inhibitor which can protect the heart against I/R injury with preservation of eNOS function and prevention of endothelial dysfunction in vivo[2]. Luteolinidin is a natural deoxyanthocyanidin, isolated from Sorghum bicolor [1]. Luteolinidin is a potent CD38 inhibitor which can protect the heart against I/R injury with preservation of eNOS function and prevention of endothelial dysfunction in vivo[2].
Pelargonidin
Pelargonidin chloride is an anthocyanidin chloride that has pelargonidin as the cationic counterpart. It has a role as a phytoestrogen and a plant metabolite. It contains a pelargonidin. An anthocyanidin chloride that has pelargonidin as the cationic counterpart. Pelargonidin chloride is a scavenger of nitric oxide radical and has antioxidant activities[1]. Pelargonidin chloride is a scavenger of nitric oxide radical and has antioxidant activities[1].
Broxuridine
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D009676 - Noxae > D000963 - Antimetabolites D011838 - Radiation-Sensitizing Agents D000970 - Antineoplastic Agents relative retention time with respect to 9-anthracene Carboxylic Acid is 0.233 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.226 5-BrdU (BrdU) is a nucleoside analog that competes with thymidine for incorporation into DNA. 5-BrdU is commonly used in the detection of proliferating cells.
4-(4-CHLORO-3-NITRO-BENZENESULFONYL)-MORPHOLINE
C10H11ClN2O5S (306.00771860000003)
4,4,5,5-tetramethyl-2-(2,4,6-trichlorophenyl)-1,3,2-dioxaborolane
C12H14BCl3O2 (306.01523840000004)
3,5-Bis(trifluoromethyl)phenyldimethylchlorosilane
C10H9ClF6Si (306.00662159999996)
2-(3,5-DICHLORO-2-HYDROXYPHENYL)-4-QUINAZOLINE
C14H8Cl2N2O2 (305.99628079999997)
4-[3-(2,4-Dichlorophenyl)isoxazol-5-yl]pyrimidin-2-amine
C13H8Cl2N4O (306.00751379999997)
7-hydroxy-3-phenyl-2-(trifluoromethyl)chromen-4-one
methyl 4-bromo-2-methyl-5-methylsulfonylbenzoate
C10H11BrO4S (305.95613860000003)
benzyl N-(6-bromo-3-pyridyl)carbamate
C13H11BrN2O2 (306.00038459999996)
tert-butyl N-(4-bromo-5-formyl-1,3-thiazol-2-yl)carbamate
6-(2-Thienyl)-2-[3-(2-thienyl)-2-aziridinyl]-3-oxa-1-azabicyclo[3.1.0]
C14H14N2O2S2 (306.04966640000004)
1-bromo-4-(diethoxyphosphorylmethyl)benzene
C11H16BrO3P (306.00203760000005)
6-BROMO-1-(TETRAHYDRO-2H-PYRAN-2-YL)NAPHTHALEN-2-OL
2-(4-CHLOROPHENYL)-4,4-BIS(METHYLTHIO)-1,3-BUTADIEN-1,1-DICARBONITRILE
2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid compound with sulfuric acid (1:1)
Benzyl (5-bromopyridin-3-yl)carbamate
C13H11BrN2O2 (306.00038459999996)
3-iodoadamantane-1-carboxylic acid
C11H15IO2 (306.01167599999997)
Ethyl 2-(6-Nitro-2,3-dichlorobenzyl)glycine
C11H12Cl2N2O4 (306.01740920000003)
Sodium 5-oxo-1-(4-sulfophenyl)-4H-pyrazole-3-carboxylate
C10H7N2NaO6S (305.99225220000005)
Glycine,N-[(2,3-dichloro-6-nitrophenyl)methyl]-, ethyl ester, hydrochloride (1:1)
C11H12Cl2N2O4 (306.01740920000003)
3,4,5-Trichlorophenylboronic acid, pinacol ester
C12H14BCl3O2 (306.01523840000004)
Methyl [(4-chloro-3-cyano-7-methoxy-6-quinolinyl)oxy]acetate
4-(S)-1-Des(methylamine)-1-oxo-2-(R,S)-hydroxy Sertraline
1,4-Diamino-2,3-dichloro-9,10-anthraquinone
C14H8Cl2N2O2 (305.99628079999997)
(5-bromo-2-propanoylphenyl) methanesulfonate
C10H11BrO4S (305.95613860000003)
2-Chloro-1,3-bis(dimethylamino)trimethinium hexafluorophosphate
tert-Butyl (2-bromo-6-chloropyridin-3-yl)carbamate
Thiazolo[5,4-g]quinoline-7-carboxylic acid,5-ethyl-2,3,5,8-tetrahydro-8-oxo-2-thioxo-
4-amino-2-[(2-chlorophenoxy)methyl]-6-methylsulfanylpyrimidine-5-carbonitrile
3-(2-METHOXY BENZYLOXY)-1-IODO PROPANE
C11H15IO2 (306.01167599999997)
N-(5-bromo-2-methoxypyridin-3-yl)cyclopropanesulfonamide
N,N-Dimethyl-10H-phenothiazine-2-sulfonamide
C14H14N2O2S2 (306.04966640000004)
2-[[3,5-bis(trifluoromethyl)phenyl]hydrazinylidene]propanedinitrile
5-(3,3-DIMETHYL-UREIDO)-2-ETHOXY-BENZENESULFONYL CHLORIDE
ACETIC ACID ACETOXY-(4-CHLORO SULFONYL PHENYL)METHYL ESTER
Benzyl (5-bromopyridin-2-yl)carbamate
C13H11BrN2O2 (306.00038459999996)
3-(5,6-dichloro-1-benzofuran-2-yl)benzoic acid
C15H8Cl2O3 (305.98504779999996)
3-Ethyl-5-[3-ethyl-2(3H)-benzothiazolylidene]-2-thioxo-4-oxazolidinone
C14H14N2O2S2 (306.04966640000004)
2-amino-3-(2-Methoxybenzoyl)-5-bromopyridine
C13H11BrN2O2 (306.00038459999996)
2-Chloro-1,3-bis(dimentylamino)trimethinium hexafluorophosphate
Cyclohexadienyliumiron(0) tricarbonyl tetrafluoroborate
C9H7BF4FeO3 (305.97737399999994)
methyl 2-(trimethylstannyl)thiophene-3-carboxylate
Phenylphosphinic acid magnesium salt
C12H12MgO4P2 (306.00613119999997)
TERT-BUTYL (5-BROMO-2-CHLOROPYRIDIN-3-YL)CARBAMATE
3-(3-Bromo-4-methoxyphenyl)benzoic acid, 2-Bromo-4-(3-carboxyphenyl)anisole, 3-Bromo-3-carboxy-4-methoxybiphenyl
2-(2,4-DIFLUORO-PHENYL)-5-THIOPHEN-2-YL-2H-PYRAZOLE-3-CARBOXYLIC ACID
3-[(2-chloro-6-fluorophenyl)methyl]-7,8-dihydro-6H-chromene-2,5-dione
C16H12ClFO3 (306.04589639999995)
4-BROMO-3-(4-FLUOROPHENYL)PROPIOPHENONE
C15H12BrFO (306.00554939999995)
(5-BROMO-2-HYDROXY-4-METHOXYPHENYL)(PHENYL)METHANONE
6-Chloro-2-(1-furo[2,3-c]pyridin-5-yl-ethylsulfanyl)-pyrimidin-4-ylamine
2-[(4-Phenoxyphenyl)sulfonylmethyl]thiirane
C15H14O3S2 (306.03843340000003)
3-(2,4-dichlorophenyl)-7-hydroxy-4H-chromen-4-one
C15H8Cl2O3 (305.98504779999996)
2-[(2-bromophenyl)methoxy]benzoic Acid
ML-097 (CID-2160985) is a pan Ras-related GTPases activator that can activate Rac1, cell division cycle 42, Ras, and Rab7[1].
5-chloro-N-(1,3-dioxo-5-isoindolyl)-2-thiophenecarboxamide
Deoxyuridine-phosphate
C9H11N2O8P-2 (306.02530160000003)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
5,5,6,6-Tetrahydroxybiphenyl-3,3-dicarboxylic acid
3-[(2Z)-3-Hydroxy-4-phenyl-5-oxofuran-2(5H)-ylidene]benzofuran-2(3H)-one
4-Hydroxy-5-(3,4-dihydroxyphenyl)-valeric acid 4-sulfate
N-(6-chloro-1,3-benzothiazol-2-yl)-1,5-dimethyl-3-pyrazolecarboxamide
2-[5-[2-[(4-Methylphenyl)thio]-1-oxoethyl]-2-thiophenyl]acetic acid
C15H14O3S2 (306.03843340000003)
N-(3-chloro-4-fluorophenyl)-5-pyridin-4-yl-1,3,4-thiadiazol-2-amine
3-chloro-4-fluoro-N-(3-pyridinyl)-1-benzothiophene-2-carboxamide
2-chloro-7,9-dihydroxy-3-methoxy-1-methyl-6H-benzo[c]chromen-6-one
(NZ)-N-(6-bromo-9-ethyl-3,4-dihydro-2H-carbazol-1-ylidene)hydroxylamine
2,3-cyclic ump
C9H11N2O8P (306.02530160000003)
A 2,3-cyclic pyrimidine nucleotide in which uridine is the parent nucleoside.
2-(3,4-Dihydroxybenzoyloxy)-4,6-dihydroxybenzoic acid
4-(5-O-phospho-beta-D-ribofuranosyl)phenol
A ribose monophosphate that is D-ribofuranose 5-phosphate in which the anomeric OH group is replaced by a 4-hydroxy phenyl group (the beta-D-anomer).
dUMP(2-)
C9H11N2O8P (306.02530160000003)
A 2-deoxyribonucleoside 5-monophosphate(2-) obtained by deprotonation of the phosphate OH groups of 2-deoxyuridine 5-monophosphate (dUMP); major species at pH 7.3.
3,5-cyclic UMP
C9H11N2O8P (306.02530160000003)
A 3,5-cyclic pyrimidine nucleotide having uridine as the nucleobase.
1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one
A differentiation-inducing factor that is hexaphenone bearing two chloro substituents at positions 3 and 5, two hydroxy substituents at positions 2 and 6 as well as a single methoxy substituent at position 4. A secreted, chlorinated molecule that controls cell fate during development of Dictyostelium cells.
4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphate
palmariol B
A benzochromenone that is 6H-benzo[c]chromen-6-one which is substituted by a methyl group at position 1, chloro group at position 2, hydroxy groups at positions positions 3 and 7, and by a methoxy group at position 9.
hyalodendriol C
An organic heterotricyclic compound that is 6H-benzo[c]chromen-6-one substituted by a methyl group at position 1, chloro group at position 2, methoxy group at position 3, and by hydroxy groups at positions 7 and 9. It is a metabolite isolated from Hyalodendriella species.
2′-Bromo-2′-deoxyuridine
2′-Bromo-2′-deoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].